These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36847619)

  • 21. Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis.
    Sakata R; Fujishiro T; Saito H; Nakamura N; Honjo M; Shirato S; Miyamoto E; Yamada Y; Aihara M
    Jpn J Ophthalmol; 2021 Sep; 65(5):591-597. PubMed ID: 34283308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on Prostaglandin Orbitopathy.
    Custer PL; Kent TL
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):102-5. PubMed ID: 25719374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases.
    Yoshino T; Fukuchi T; Togano T; Seki M; Ikegaki H; Abe H
    Jpn J Ophthalmol; 2013 Mar; 57(2):172-8. PubMed ID: 23208023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deepening of eyelid superior sulcus during topical travoprost treatment.
    Yang HK; Park KH; Kim TW; Kim DM
    Jpn J Ophthalmol; 2009 Mar; 53(2):176-179. PubMed ID: 19333704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease.
    Eiger-Moscovich M; Stiebel-Kalish H; Yassur I; Barash D; Gaton D; Avisar I
    Can J Ophthalmol; 2019 Aug; 54(4):426-430. PubMed ID: 31358139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin Eyedrops Are Associated With Decreased Thicknesses of Eyelid Dermis and Orbicularis Oculi Muscle: Ultrasonographic Findings.
    Goh AS; Nassiri N; Kohn JC; Rootman DB; Giaconi J; Law SK; Coleman AL; Caprioli J; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2016; 32(5):337-41. PubMed ID: 26237530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermatological adverse effects of anti-glaucoma eye drops: a review.
    Patchinsky A; Petitpain N; Gillet P; Angioi-Duprez K; Schmutz JL; Bursztejn AC
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):661-670. PubMed ID: 35032359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latanoprost therapy after sunken eyes caused by travoprost or bimatoprost.
    Nakakura S; Tabuchi H; Kiuchi Y
    Optom Vis Sci; 2011 Sep; 88(9):1140-4. PubMed ID: 21666524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between personality traits and experience of adverse periocular reactions to topical prostaglandin analogues.
    Kishimoto N; Noro T; Kodaka F; Kurosawa M; Itoh Y; Ogawa S; Watanabe T; Kubota M; Hori K; Shigeta M; Nakano T
    BMJ Open Ophthalmol; 2022 Jun; 7(1):. PubMed ID: 36161860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral deepening of upper lid sulcus from topical bimatoprost therapy.
    Yam JC; Yuen NS; Chan CW
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):471-2. PubMed ID: 19857110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost.
    Sakata R; Shirato S; Miyata K; Aihara M
    Jpn J Ophthalmol; 2013 Mar; 57(2):179-84. PubMed ID: 23233196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin-Associated Periorbital Lipodystrophy in Cosmetic Eyelid Surgery: A Novel Cause of Facial Asymmetry.
    Eftekhari K; Mifflin MD; Anderson RL
    Aesthet Surg J; 2016 Mar; 36(3):NP119-21. PubMed ID: 26374814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin-associated periorbitopathy.
    Shrirao N; Khurana M; Mukherjee B
    Indian J Ophthalmol; 2016 Jun; 64(6):459. PubMed ID: 27488155
    [No Abstract]   [Full Text] [Related]  

  • 35. Periorbital changes associated with topical bimatoprost.
    Filippopoulos T; Paula JS; Torun N; Hatton MP; Pasquale LR; Grosskreutz CL
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):302-7. PubMed ID: 18645437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.
    Servat JJ; Bernardino CR
    Drugs Aging; 2011 Apr; 28(4):267-82. PubMed ID: 21428462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
    Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
    Adv Ther; 2015 Sep; 32(9):823-37. PubMed ID: 26424331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periocular skin hyperpigmentation in children treated with prostaglandin analogues.
    Al-Zobidi M; Khandekar R; Craven ER; Hanafi S; Edward DP
    J AAPOS; 2015 Feb; 19(1):49-53. PubMed ID: 25727587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report.
    Villegas VM; Díaz L; Izquierdo NJ
    P R Health Sci J; 2008 Dec; 27(4):348-9. PubMed ID: 19069363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features.
    Shah M; Lee G; Lefebvre DR; Kronberg B; Loomis S; Brauner SC; Turalba A; Rhee DJ; Freitag SK; Pasquale LR
    PLoS One; 2013; 8(5):e61638. PubMed ID: 23650502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.